Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing at Premium to Market (The Malaysian Reserve) - Feb 20, 2026 - "The financing was structured to reflect the company’s current operational momentum and the underlying value of its NurOwn platform....Proceeds from the financing will be used to support ongoing regulatory initiatives, prepayments for the upcoming Phase 3b trial of NurOwn in ALS, and general corporate purposes."
Financing • New P3 trial • Amyotrophic Lateral Sclerosis
|